Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
Key facts
- Who runs it
- University of Maryland, College Park
- Where
- Baltimore, College Park, Denton, and Washington D.C., United StatesSee the 4 sites
- Trial code
- Status
- Recruiting
- People taking part
- 160 people, planned
- Started
- 15 Jun 2023
- Expected to end
- 1 Sept 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Peer-Delivered Behavioral Activation ("Peer Activate")
- Record updated
- 27 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Patient participants in the RCT must be 18 or older; receive OUD treatment as part of the telemedicine program; and exhibit polysubstance use within the past three-months (i.e., use of one or more non-prescribed substances (excluding opioids and/or tobacco) by urine toxicology or self-report
Who cannot take part
- Demonstrating active, unstable or untreated psychiatric symptoms, including mania and/or psychosis that would interfere with study participation
- Inability to understand the study and provide informed consent in English
This trial is currently available in United States.
- University of Maryland Baltimore (UMD Drug Treatment Center)Baltimore, United StatesContact: Heather FitzsimonsNot yet recruiting
- University of Maryland, College ParkCollege Park, United StatesContact: Morgan S Anvari, BANot yet recruiting
- Caroline County Behavioral HealthDenton, United StatesContact: Jessica Tuel, MSWTaking people
- HIPS ClinicWashington D.C., United StatesContact: Sarah M. Kattakuzhy, MDNot yet recruiting
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among patients with OUD and polysubstance use in underserved areas. The intervention is based on behavioral activation (BA) and is specifically designed to be implemented by a trained peer recovery specialist. In this hybrid, Type-1 effectiveness-implementation randomized controlled trial (RCT), the investigators will evaluate the effectiveness and implementation of Peer Activate vs. treatment as usual (TAU) over twelve months.
The 2 groups in the trial
- Peer-Delivered Behavioral Activation ("Peer Activate")Treatment being tested
Participants in the Peer Activate intervention will receive a PRS-delivered behavioral activation intervention to address barriers to retention in methadone treatment and increase substance-free, positive reinforcement to support retention and reduce polysubstance use.
- Treatment As UsualNo study treatment, for comparison
Participants in the TAU group will receive enhanced treatment as usual, defined as MTU services as usual enhanced with additional community referrals and follow-ups on those referrals, in addition to regular meetings with an addiction medicine physician and PRS on the MTU. Standard PRS contact typically includes connection to local resources and general peer support as needed.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Peer-Delivered, Behavioral Activation Intervention to Improve Polysubstance Use and Retention in Mobile Telemedicine OUD Treatment in an Underserved, Rural Area
- Record updated
- 27 April 2026